SCHEMBL11813541

SCHEMBL11813541

CCc1cc(C(O)CNC(C)CC)ccc1SC

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADRB2 P07550 11/20 0.41
▸ MAPT P10636 5/20 0.41
▸ TSHR P16473 4/20 0.41
▸ KDM4E B2RXH2 4/20 0.41
▸ TDP1 Q9NUW8 4/20 0.41
▸ ADRB1 P08588 3/20 0.41
▸ MAPK1 P28482 3/20 0.41
▸ HSD17B10 Q99714 3/20 0.41
▸ MEN1 O00255 3/20 0.41
▸ CYP1A2 P05177 3/20 0.41
▸ KMT2A Q03164 3/20 0.41
▸ HIF1A Q16665 3/20 0.41
▸ ADRB3 P13945 2/20 0.41
▸ MTOR P42345 2/20 0.41
▸ LMNA P02545 2/20 0.41
▸ CYP3A4 P08684 2/20 0.41
▸ NFKB1 P19838 2/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ HPGD P15428 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11811349 0.89 MAPT (0.54) ADRB2MAPTTSHRKDM4ETDP1
SCHEMBL11809441 0.85 ADRB2 (0.42) ADRB2MAPTTSHRKDM4ETDP1
Hydrochloric Acid SCHEMBL11810810 0.84 ADRB2 (0.43) ADRB2MAPTTSHRKDM4ETDP1
SCHEMBL11812508 0.84 ADRB1 (0.41) ADRB2MAPTTSHRKDM4ETDP1
SCHEMBL25893866 0.75 ADRB2 (0.62) ADRB2MAPTTSHRKDM4ETDP1
Hydrochloric Acid SCHEMBL4387242 0.73 MAPT (0.74) ADRB2MAPTTSHRKDM4ETDP1
SCHEMBL14137931 0.71 SLC22A3 (0.61) ADRB2MAPTTSHRKDM4ETDP1
SCHEMBL11805102 0.71 ADRB2 (0.56) ADRB2MAPTTSHRKDM4ETDP1
SCHEMBL19329750 0.71 ADRB2 (0.67) ADRB2TSHRKDM4ETDP1ADRB1
SCHEMBL11807914 0.70 ADRB2 (0.57) ADRB2MAPTTSHRKDM4ETDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-3954871-A ANTIARRHYTHMIA, VASODILATOR, HYPOTENSIVE CONTINENTAL PHARMA (BE) 1976-05-04 — — US disclosed
Send feedback